You can choose the size of the video you would like to embed below. Next, copy the embed code that is available in the box below. Paste this code on to your website to display the video.
If you experience problems embedding videos, please contact us.
Financial News Network
February 07, 2011 AT 6:24 PM
Optimer Pharmaceuticals Inc. (OPTR) is up 6.25% to $12.58 in mid-morning trading and, but still well off its 52-week high of $13.80. The jump comes on the back of a licensing deal for its experimental antibiotic, fidaxomicin, with Japanese drugmaker Astellas Pharma Inc.'s European unit. The upfront payment will be $68 million.